Global Cosmetic Compliance
Intelligence & Solutions
Home / News / Details

Australia Releases Completed Evaluation Statements of the Rolling Action Plan

The AICIS has updated the completed chemical evaluations, including four evaluation statements related to cosmetic use.

Background

Australia’s Evaluations Roadmap describes a strategic approach to protect human health and the environment, which is achieved by providing information and recommendations about managing the risks that arise from introducing and using industrial chemicals. By prioritizing chemicals on the Australian Inventory of Industrial Chemicals (the Inventory), the evaluations become more risk-proportionate, timely, and targeted.

The Rolling Action Plan forms an essential part of the approach. It serves as a work plan that prioritizes chemicals for evaluation, encompassing proposed, ongoing, and recently completed evaluations based on the outcomes of the Evaluation Selection Analysis (ESA) process.

For each entry, the Rolling Action Plan includes:

  • The subject of the evaluation: typically the chemical’s name or the chemical group’s name

  • Reason for the evaluation

  • The time it takes to evaluate

  • The focus of the evaluation: chemical identity, and human health or the environment (or both)

  • The amendments to the list of evaluation candidates

Released Evaluation Statements

On December 16, the Australian Industrial Chemicals Introduction Scheme (AICIS) published eight completed evaluations under Section 78 of the Industrial Chemicals Act 2019, assessing the human health and environmental risks of certain chemicals listed on the Inventory. These evaluations have now been updated into the Rolling Action Plan.

Among the eight statements, four chemical evaluations pertain to cosmetic use. Detailed information on these evaluations is listed below:

ID

Subject of Evaluation

Reasons for Evaluation

Timeframe

Focus

Status Reason

EVA00122

1H-Benzotriazole and its mono-substituted derivatives

Evaluation Selection Analysis indicated a potential human health risk

31/12/2024

Health

Completed

EVA00147

Phenolic benzotriazoles

Evaluation Selection Analysis indicated a potential human health risk

31/12/2024

Health

Completed

EVA00153

Extracts and essential oils primarily composed of methyl salicylate

Evaluation Selection Analysis indicated a potential human health risk.

31/12/2024

Health

Completed

EVA00162

Benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester (Homosalate)

Evaluation Selection Analysis indicated a potential human health and environmental risk.

30/6/2025

Health and Environment

Completed

We provide full-scale global cosmetic market entry services (including cosmetic registering & filing, regulatory consultation, customized training, market research, branding strategy). Please contact us to discuss how we can help you by [email protected]
Copyright: unless otherwise stated all contents of this website are ©2026 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact [email protected]
User Guide